Crossmark

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers

Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-O7

Published Online: 2015-11-04

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gangadhar, Tara C

Hamid, Omid

Smith, David C

Bauer, Todd M

Wasser, Jeffrey S

Luke, Jason J

Balmanoukian, Ani S

Kaufman, David R

Zhao, Yufan

Maleski, Janet

Leopold, Lance

Gajewski, Thomas F
More Information

Article History

First Online: 4 November 2015